The next [generational / generation] of weight-loss drugs could be launched next year, and they could [been / be] game-changing. The treatment, being [daubed / dubbed] "Ozempic 2.0," is a pill [aversion / version] of the already widely-used Ozempic. Novo Nordisk, the pharmaceutical company developing the new tablet form, said its [initial / initially] clinical trials revealed that Ozempic 2.0 "[slowed / lowered] weight by an average of 10.5 per cent". Rival company Eli Lilly is also working [in / on] a pill. Its executive vice president, Kenneth Custer, said: "We are moving [with / for] urgency toward global regulatory submissions to potentially meet the [needy / needs] of patients." The drugs are currently awaiting [approval / approve] from the Food and Drug Administration (FDA) in the USA.
The game-changing medicines could make life much easier for [them / those] hoping to [shed / shade] weight, and for people with diabetes. Eli Lilly Chief Scientific Officer Dan Skovronsky said: "For the majority [of / in] patients, this could be the [main / mainly] medicine that they need to control their type 2 diabetes as well as their obesity." Currently, the drug is [admonished / administered] in the [form / frame] of a once-weekly injection via an injectable pen. The pen has to be [refrigerating / refrigerated] . Mr Custer told reporters: "If [approved / approval] , we are ready to offer a convenient, once-daily pill that can be [scales / scaled] globally, removing barriers and redefining how obesity is treated around the world." It is also [likelihood / likely] that the new treatment will be cheaper.
